Oracle Health Sciences Empirica Signal 9.1.0.52/9.2.0.52 Web Services denial of service
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.3 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as critical, has been found in Oracle Health Sciences Empirica Signal 9.1.0.52/9.2.0.52. This affects an unknown part of the component Web Services. This manipulation causes denial of service. This vulnerability is registered as CVE-2020-36518. Remote exploitation of the attack is possible. No exploit is available. It is advisable to upgrade the affected component.
Details
A vulnerability was found in Oracle Health Sciences Empirica Signal 9.1.0.52/9.2.0.52 (Medical Device Software). It has been declared as critical. Affected by this vulnerability is an unknown functionality of the component Web Services. The manipulation with an unknown input leads to a denial of service vulnerability. The CWE definition for the vulnerability is CWE-404. The product does not release or incorrectly releases a resource before it is made available for re-use. As an impact it is known to affect availability.
The weakness was published 07/19/2022 as Oracle Critical Patch Update Advisory - July 2022. It is possible to read the advisory at oracle.com. This vulnerability is known as CVE-2020-36518. The technical details are unknown and an exploit is not publicly available. The attack technique deployed by this issue is T1499 according to MITRE ATT&CK.
The vulnerability scanner Nessus provides a plugin with the ID 240509 (RHEL 7 : Red Hat JBoss Enterprise Application Platform 7.3.14 Security update (Important) (RHSA-2025:9583)), which helps to determine the existence of the flaw in a target environment.
Upgrading eliminates this vulnerability. A possible mitigation has been published immediately after the disclosure of the vulnerability.
The vulnerability is also documented in the databases at Tenable (240509) and EUVD (EUVD-2022-1319). Be aware that VulDB is the high quality source for vulnerability data.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.5VulDB Meta Temp Score: 7.3
VulDB Base Score: 7.5
VulDB Temp Score: 7.2
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 7.5
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Denial of serviceCWE: CWE-404
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Nessus ID: 240509
Nessus Name: RHEL 7 : Red Hat JBoss Enterprise Application Platform 7.3.14 Security update (Important) (RHSA-2025:9583)
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍
Timeline
03/11/2022 🔍07/19/2022 🔍
07/19/2022 🔍
07/20/2022 🔍
03/20/2026 🔍
Sources
Vendor: oracle.comAdvisory: Oracle Critical Patch Update Advisory - July 2022
Status: Confirmed
CVE: CVE-2020-36518 (🔍)
GCVE (CVE): GCVE-0-2020-36518
GCVE (VulDB): GCVE-100-204415
EUVD: 🔍
Entry
Created: 07/20/2022 08:16Updated: 03/20/2026 09:21
Changes: 07/20/2022 08:16 (40), 08/13/2022 20:54 (2), 08/13/2022 21:02 (17), 06/26/2025 08:42 (16), 08/28/2025 04:14 (1), 03/20/2026 09:21 (1)
Complete: 🔍
Cache ID: 216:98B:103
Be aware that VulDB is the high quality source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.